Delhi HC Refuses Interim Relief to Sun Pharma Against Mylan Lab on Oxaliplatin Trademark Case - 13.02.2017

Delhi High Court has refused to provide Sun Pharmaceuticals any interim relief in their trademark infringement case against rival drug manufacturer Mylan Laboratories for production of cancer medication Oxaliplatin.

Tags : Delhi High Court Mylan Laboratories Oxaliplatin

Share :